“Photon counting in computed tomography is the holy grail”

Erik Fredenberg, a researcher in physics at KTH and GE, is working to implement photon-counting CT in clinics. To shorten lead times and reduce the radiation do...

Acquisition of consulting company Key2Compliance

The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.

Pharma Outsourcing igång på Stockholm Waterfront

Nya rekryteringar hos Enzymatica

Utöver de nya rekryteringarna sker även organisationsförändringar i bolaget.

Eternal Rye – Improving Plant Breeding Methods

User story from Martin Luther University Halle.

EU Pharmaceutical Legislation Reform

The EU's Pharmaceutical Legislation Reform, proposed by the commission within the European Health Union, aims to establish a citizen-centric framework to enhanc...

Vicore tar in en halv miljard inför studie i lungfibros

Vicore Pharma tillförs en halv miljard kronor i en riktad nyemission. Syftet med kapitaltillskottet är att kunna fortsätta utvecklingen av bolagets behandlingar...

The art of building a biologic drug

The first biosimilar from Xbrane Biopharma was launched earlier this year, and several more are under development at the company’s facility in Solna, Sweden. “W...

Column: Repurposing as a golden ticket to approval

"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...

Årets opinionsartiklar 2023

Nu lider 2023 mot sitt slut. Här är några av krönikorna, debattartiklarna och ledarna från det gångna året från Life Science Sweden och systertidningarna Medtec...

Swedish breakthrough in Alzheimer’s: “We can finally present great data”

Treatments for Alzheimer’s disease are currently among the hottest topics in drug development. Two Swedish research companies with high ambitions and successes ...

Bio Europe to Stockholm – ”The Swedish ecosystem is now taking the opportunity”

The international life science conference Bio Europe is coming to Sweden for the first time in November. The conference, whose program takes inspiration from AB...

Höstens mest lästa krönikor

Här nedan läser du de mest lästa krönikorna i Life Science Sweden och systertidningen Medtech Magazine från hösten och vintern.

Nanexa develops depot formulation of the diabetes and obesity drug Saxenda

Uppsala-based company Nanexa has signed an agreement with a German contract research company to start a clinical study with a monthly depot of liraglutide. The ...

Revealing the secrets of a part

CT inspection in automation technology at Festo.

”We need compatibility“

Penilla Gunther, founder of Fokus Patient and chair of the European Patient Safety Foundation, hopes that the forthcoming life science strategy will focus on ef...

Ny chef på Key2compliance: “Lite mindre konventionell”

Affärsutvecklaren och projektledaren Jeanette Demorney blir ny affärsområdeschef för clinical development på Key2compliance.

Ny vd för AOP Orphan Pharmaceuticals

AOP Orphan Pharmaceuticals har utsett Sofia Opitz till ny vd. Hon kommer närmast från en tjänst som Country Manager för Sverige, Norge och Danmark på företaget Biocodex.

Total pipeline of pharmaceutical companies reaches a record high – 22,921 medicines are currently being developed

Despite the difficult economic times, pharmaceutical companies have never developed as many new drugs as now.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

Förlikning i babypuderskandal stoppas av domstol

Det amerikanska läkemedelsbolaget Johnson & Johnson har för en andra gång fått avslag av en domare om en konkursansökan för dotterbolaget LTL Management, mest k...

Hon ska leda PCG:s projekt

Johanna Sundberg tar plats som Director Project Management på kontraktsforskningsföretaget.

She creates pharmaceuticals on a 3D printer

The correct dosage for each individual, regardless of whether the pharmaceutical is for a seriously ill child or a frail elderly person, is the mission of a well-advanced project...

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.